AGP Executive Report
Last update: an hour agoHepatitis B Trial: Danish university ethics officials approved a controversial study in Guinea-Bissau that would give the birth-dose vaccine to half of 14,000 newborns and delay it for six weeks for the rest. Guinea-Bissau officials have also reportedly approved the project, while the CDC is said to have set aside $1.6 million in funding. Health experts warn that withholding a proven vaccine could put babies at risk of lifelong infection; nearly one in five people in the country is infected with hepatitis B. Regional Disease Preparedness: ECOWAS animal-health officials met in Lomé to strengthen cross-border surveillance and control of threats including avian influenza, rabies and foot-and-mouth disease. Better coordination could help protect livestock, food supplies and livelihoods across West Africa.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
